BIRC5 and central nervous system cancer: In order to study the mechanism of scutellarin against glioma, the target of scutellarin was queried using The Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform, and then intersected with DEGs in glioma to obtain two key targets, BIRC5 and collagen, type III, alpha 1 (COL3A1) (Figure 4C).